Thioredoxin-1 gene therapy enhances angiogenic signaling and reduces ventricular remodeling in infarcted myocardium of diabetic rats
about
Gene therapy for ischemic heart diseaseEndothelial dysfunction in diabetes mellitus: possible involvement of endoplasmic reticulum stress?Thioredoxin/Txnip: redoxisome, as a redox switch for the pathogenesis of diseasesRedox balance dynamically regulates vascular growth and remodelingThioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signalingPrenatal exposure to lipopolysaccharide results in myocardial remodelling in adult murine offspring.Targets and delivery methods for therapeutic angiogenesis in peripheral artery diseaseCaloric restriction confers persistent anti-oxidative, pro-angiogenic, and anti-inflammatory effects and promotes anti-aging miRNA expression profile in cerebromicrovascular endothelial cells of aged rats.Glutaredoxin-1 overexpression enhances neovascularization and diminishes ventricular remodeling in chronic myocardial infarction.The protective effect of microRNA-320 on left ventricular remodeling after myocardial ischemia-reperfusion injury in the rat model.Modulation of signaling mechanisms in the heart by thioredoxin 1.The emerging role of the thioredoxin system in angiogenesisDisruption of hypoxia-inducible transcription factor-prolyl hydroxylase domain-1 (PHD-1-/-) attenuates ex vivo myocardial ischemia/reperfusion injury through hypoxia-inducible factor-1α transcription factor and its target genes in mice.Thioredoxin-2 inhibits mitochondrial reactive oxygen species generation and apoptosis stress kinase-1 activity to maintain cardiac function.Xiaokening stimulates endothelial nitric oxide release in diabetic rats.Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice.Thioredoxin 1 enhances neovascularization and reduces ventricular remodeling during chronic myocardial infarction: a study using thioredoxin 1 transgenic miceDisruption of Nrf2 signaling impairs angiogenic capacity of endothelial cells: implications for microvascular aging.Oxidative stress contributes to the impaired sonic hedgehog pathway in type 1 diabetic mice with myocardial infarction.Circulating factors induced by caloric restriction in the nonhuman primate Macaca mulatta activate angiogenic processes in endothelial cells.HECT-Type Ubiquitin E3 Ligase ITCH Interacts With Thioredoxin-Interacting Protein and Ameliorates Reactive Oxygen Species-Induced Cardiotoxicity.PX-12-induced HeLa cell death is associated with oxidative stress and GSH depletion.A critical role for thioredoxin-interacting protein in diabetes-related impairment of angiogenesis.Application of recombinant thioredoxin1 for treatment of heart disease.Oxidative stress in heart failure: what are we missing?Diabetes, oxidative stress, molecular mechanism, and cardiovascular disease--an overview.Cell stress proteins in atherothrombosisInteracting with thioredoxin-1--disease or no disease?Genetics and genomics of ischemic tolerance: focus on cardiac and cerebral ischemic preconditioning.Diabetic cardiomyopathy and its mechanisms: Role of oxidative stress and damage.Oxidative stress in severe acute illness.Thioredoxin superfamily and its effects on cardiac physiology and pathology.ROS signaling and redox biology in endothelial cells.Thioredoxins in cardiovascular disease.Regulation of A-Kinase-Anchoring Protein 12 by Heat Shock Protein A12B to Prevent Ventricular Dysfunction Following Acute Myocardial Infarction in Diabetic Rats.Trimodal rescue of hind limb ischemia with growth factors, cells, and nanocarriers: fundamentals to clinical trials.Epalrestat increases glutathione, thioredoxin, and heme oxygenase-1 by stimulating Nrf2 pathway in endothelial cells.Mechanistic Role of Thioredoxin 2 in Heart Failure.The role of the thioredoxin/thioredoxin reductase system in the metabolic syndrome: towards a possible prognostic marker?Protective effects of Phyllanthus emblica against myocardial ischemia-reperfusion injury: the role of PI3-kinase/glycogen synthase kinase 3β/β-catenin pathway.
P2860
Q24632135-285DD891-C893-4A69-BCBA-368D0B540FC1Q26851362-FB18324A-2EB3-435C-ACA0-5E4AB38F40B2Q27003070-D6BFE99E-CCE0-4BA9-AB44-79F5FB9E2CCDQ27004547-D5BFDBCD-2B12-4A4E-AA16-42C9DD7C8FDFQ28389739-02EA3A37-E6D2-4D19-B1F1-4628ADF9299CQ30445274-3892DC06-87B9-488B-80DE-D330182D156FQ30449821-092055A2-3D81-4DDC-B465-9E133C2FCABCQ34001695-28B60C5D-F285-4CE2-89A9-E2FDDD3FDA3AQ34241559-B51EFC44-0ACC-4F27-AF68-6D77C90A00E5Q34486554-7A6B7B0E-710F-4580-92CB-9C472E4C7659Q34547638-47F217F3-2FA0-4290-9DDA-34FC74FFD8B8Q35123800-23A57922-67C9-45F8-B161-D1ECF1E0E391Q35173596-FF1EC972-AD89-4070-B44B-3158AA3A9999Q35217815-A0F9C14D-6A61-4423-A76C-DA5133B5FD90Q35905038-C214D93F-D580-4DEF-8629-7B28A8A5B43EQ35922922-AEB87945-767B-4312-B5F2-58CD9B8AFF38Q36096847-E6F57B54-0E5E-4338-8552-A446A049CA47Q36112481-653E087D-C253-41CA-B9DD-B795A4E82927Q36336214-1720EFED-3BB0-404F-BD4D-DABB3FDA8B5BQ36709361-80DE084A-4CA4-45F8-846A-84C9B576EC85Q36877602-5B8E5E6D-720E-4987-B817-22ED4D85401CQ37325166-2CAE3359-1DAD-4B69-90F0-8A3503F7AC30Q37510205-D00984A2-FC12-47AB-A161-8A51B9E8C99EQ37801029-6A51AA64-64A9-4425-97EE-53069CB161BDQ37900100-DFB1B778-1ACE-4C59-8C90-0B6FC2CE1765Q37991017-4CC9798C-6085-4245-9F1D-A26D5E78D4F5Q38026043-228787E8-D49D-4F12-BCA9-19A95F1EC4CFQ38032332-CF58FD99-68FF-4D52-BE1A-772F2EAC96B2Q38061499-BFDE1C2B-1699-482A-BF50-8AE6E54DF210Q38271210-5C63E8CE-6986-4DBE-87B9-D88E2E4B6B62Q38341610-3D274CBD-28BB-41C4-9718-EEBE16856F2BQ38423835-9DB1C943-3A17-497C-BC11-4116780DB97BQ38478574-49E9FBAD-3658-4440-92D3-139C73ADD8DCQ38595062-4B9F66F3-C92C-421C-AD21-D16034B0C2FDQ38915485-4CC68F01-B947-4552-8AF2-5F28E8F9B5D0Q39240834-E1A3DA1C-CD3B-472E-9C23-8A54D11AC186Q43047088-E5A1D88D-812A-463C-A740-5DDF3B81A1D6Q46359834-12C74C63-6FDA-40E1-BE3C-BB931B18A09FQ48256915-84E372DF-9147-4367-B950-8E117736B727Q53355500-47167149-C79A-4BF4-8805-DE0A990A6C69
P2860
Thioredoxin-1 gene therapy enhances angiogenic signaling and reduces ventricular remodeling in infarcted myocardium of diabetic rats
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Thioredoxin-1 gene therapy enh ...... ed myocardium of diabetic rats
@ast
Thioredoxin-1 gene therapy enh ...... ed myocardium of diabetic rats
@en
type
label
Thioredoxin-1 gene therapy enh ...... ed myocardium of diabetic rats
@ast
Thioredoxin-1 gene therapy enh ...... ed myocardium of diabetic rats
@en
prefLabel
Thioredoxin-1 gene therapy enh ...... ed myocardium of diabetic rats
@ast
Thioredoxin-1 gene therapy enh ...... ed myocardium of diabetic rats
@en
P2093
P2860
P1433
P1476
Thioredoxin-1 gene therapy enh ...... ed myocardium of diabetic rats
@en
P2093
Gautam Maulik
Lijun Zhan
Mahesh Thirunavukkarasu
Nilanjana Maulik
Perumana R Sudhakaran
Samson Mathews Samuel
Srikanth Koneru
Suresh Varma Penumathsa
P2860
P304
P356
10.1161/CIRCULATIONAHA.109.872481
P407
P577
2010-03-01T00:00:00Z